Pfizer Skids As Covid Products Drive 41% Sales Decline, Losses
Published
Early Tuesday, Pfizer (PFE) stock dipped after the pharma mammoth reported an adjusted loss of 17 cents per share on $13.23 billion in third-quarter sales. On average, analysts polled by FactSet expected Pfizer to lose 8 cents a share and report $13.34 billion in sales. In the year-ago period,…
#pfe #pfizer #allisongatlin #twitter #ibdagatlin #drugmaker